Style | Citing Format |
---|---|
MLA | Hashemi H, et al.. "Clinical Results With Two Different Pharmaceutical Preparations of Riboflavin in Corneal Cross-Linking: An 18-Month Follow Up." DARU# Journal of Pharmaceutical Sciences, vol. 23, no. 1, 2015, pp. -. |
APA | Hashemi H, Seyedian MA, Miraftab M, Bahrmandy H, Sabzevari A, Asgari S (2015). Clinical Results With Two Different Pharmaceutical Preparations of Riboflavin in Corneal Cross-Linking: An 18-Month Follow Up. DARU# Journal of Pharmaceutical Sciences, 23(1), -. |
Chicago | Hashemi H, Seyedian MA, Miraftab M, Bahrmandy H, Sabzevari A, Asgari S. "Clinical Results With Two Different Pharmaceutical Preparations of Riboflavin in Corneal Cross-Linking: An 18-Month Follow Up." DARU# Journal of Pharmaceutical Sciences 23, no. 1 (2015): -. |
Harvard | Hashemi H et al. (2015) 'Clinical Results With Two Different Pharmaceutical Preparations of Riboflavin in Corneal Cross-Linking: An 18-Month Follow Up', DARU# Journal of Pharmaceutical Sciences, 23(1), pp. -. |
Vancouver | Hashemi H, Seyedian MA, Miraftab M, Bahrmandy H, Sabzevari A, Asgari S. Clinical Results With Two Different Pharmaceutical Preparations of Riboflavin in Corneal Cross-Linking: An 18-Month Follow Up. DARU# Journal of Pharmaceutical Sciences. 2015;23(1):-. |
BibTex | @article{ author = {Hashemi H and Seyedian MA and Miraftab M and Bahrmandy H and Sabzevari A and Asgari S}, title = {Clinical Results With Two Different Pharmaceutical Preparations of Riboflavin in Corneal Cross-Linking: An 18-Month Follow Up}, journal = {DARU# Journal of Pharmaceutical Sciences}, volume = {23}, number = {1}, pages = {-}, year = {2015} } |
RIS | TY - JOUR AU - Hashemi H AU - Seyedian MA AU - Miraftab M AU - Bahrmandy H AU - Sabzevari A AU - Asgari S TI - Clinical Results With Two Different Pharmaceutical Preparations of Riboflavin in Corneal Cross-Linking: An 18-Month Follow Up JO - DARU# Journal of Pharmaceutical Sciences VL - 23 IS - 1 SP - EP - PY - 2015 ER - |